Literature DB >> 16214921

Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.

Valérie Chaudru1, Karine Laud, Marie-Françoise Avril, Annie Minière, Agnès Chompret, Brigitte Bressac-de Paillerets, Florence Demenais.   

Abstract

Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Penetrance of CDKN2A gene was found to be significantly influenced by host factors (nevus phenotypes and sunburn) on one hand and by variants of MC1R gene (RHC variants consistently associated with red hair and fair skin) on the other hand. Our goal was to examine the joint effects of MC1R variants and other potential risk factors [total nevi, dysplastic nevi, pigmentary traits (skin, hair and eye color), skin reactions to sunlight, and degree of sun exposure] on CDKN2A penetrance. Clinical, genetic, and covariate data were recorded in 20 French melanoma-prone families with cosegregating CDKN2A mutations. Analysis of the cotransmission of melanoma and CDKN2A mutations was conducted by likelihood-based methods using the regressive logistic models, which can account for a variation of disease risk with age and can include the aforementioned risk factors as covariates. RHC variants, considered either alone or in the presence of pigmentation and nevus phenotypes, were found to increase significantly CDKN2A penetrance. Multivariate analysis, using a stepwise selection procedure, showed significant effects of two factors on melanoma risk in CDKN2A mutations carriers: RHC variants [odds ratio of hazard function (OR), 2.21; P = 0.03] and dysplastic nevi (OR, 2.93; P < 0.01). Such results may have important consequences to improve the prediction of melanoma risk in families.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214921     DOI: 10.1158/1055-9965.EPI-04-0777

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  19 in total

Review 1.  Hereditary genodermatoses with cancer predisposition.

Authors:  Meg R Gerstenblith; Alisa M Goldstein; Margaret A Tucker
Journal:  Hematol Oncol Clin North Am       Date:  2010-10       Impact factor: 3.722

Review 2.  Dysplastic nevi and melanoma.

Authors:  Alisa M Goldstein; Margaret A Tucker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

3.  Genetic and functional evaluation of MITF as a candidate gene for cutaneous melanoma predisposition in pigs.

Authors:  Emmanuelle Bourneuf; Zhi-Qiang Du; Jordi Estellé; Hélène Gilbert; Françoise Créchet; Guillaume Piton; Denis Milan; Claudine Geffrotin; Mark Lathrop; Florence Demenais; Claire Rogel-Gaillard; Silvia Vincent-Naulleau
Journal:  Mamm Genome       Date:  2011-05-28       Impact factor: 2.957

4.  Benefits of oral Polypodium Leucotomos extract in MM high-risk patients.

Authors:  P Aguilera; C Carrera; J A Puig-Butille; C Badenas; M Lecha; S González; J Malvehy; S Puig
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-07-31       Impact factor: 6.166

5.  Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Authors:  F Demenais; H Mohamdi; V Chaudru; A M Goldstein; J A Newton Bishop; D T Bishop; P A Kanetsky; N K Hayward; E Gillanders; D E Elder; M F Avril; E Azizi; P van Belle; W Bergman; G Bianchi-Scarrà; B Bressac-de Paillerets; D Calista; C Carrera; J Hansson; M Harland; D Hogg; V Höiom; E A Holland; C Ingvar; M T Landi; J M Lang; R M Mackie; G J Mann; M E Ming; C J Njauw; H Olsson; J Palmer; L Pastorino; S Puig; J Randerson-Moor; M Stark; H Tsao; M A Tucker; P van der Velden; X R Yang; N Gruis
Journal:  J Natl Cancer Inst       Date:  2010-09-28       Impact factor: 13.506

6.  Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.

Authors:  Xiaohong Rose Yang; Ruth M Pfeiffer; William Wheeler; Meredith Yeager; Stephen Chanock; Margaret A Tucker; Alisa M Goldstein
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

7.  Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes.

Authors:  Valérie Chaudru; M T Lo; F Lesueur; C Marian; H Mohamdi; K Laud; M Barrois; A Chompret; M F Avril; F Demenais; B Bressac-de Paillerets
Journal:  Fam Cancer       Date:  2009-05-31       Impact factor: 2.375

8.  Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population.

Authors:  J A Puig-Butillé; C Carrera; R Kumar; Z Garcia-Casado; C Badenas; P Aguilera; J Malvehy; E Nagore; S Puig
Journal:  Br J Dermatol       Date:  2013-10       Impact factor: 9.302

Review 9.  Progress in the epidemiological understanding of gene-environment interactions in major diseases: cancer.

Authors:  Jacqueline Clavel
Journal:  C R Biol       Date:  2007-04-05       Impact factor: 1.583

10.  Some molecular and clinical aspects of genetic predisposition to malignant melanoma and tumours of various site of origin.

Authors:  Tadeusz Debniak
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.